Unfortunately the virtual stupidity of selling here despite the enormity of the HerVax data is just a super sad reflection of the short sighted mentality of only one segment of the market, and a handful of opportunistic fly by night punters who will already be onto their next stock without knowing exactly what it is they are buying.
Buying two weeks ago for an average price of say 8c, and locking in a 40 % profit now is all they care about. The implications of the data mean nothing. End of year bonus for some might even be foremost on their mind. Wouldn't surprise me if it's the same deluded mob who bought in the previous cap raise at 3.6 and then sold out from 2.8 and lower. And they had prior form on the board the time before.
Rest assured , however, there is another segment of the register that is holding firm and fully understands the long term nature and the potential financial outcome of holding for another 12 _24 months minimum. As a top 20 holder, and knowing a few others with similar size shareholdings, the four year wait, the average entry of less than 1.5 , the paper profit on offer here, it all means absolutely nothing in comparison to waiting patiently for the game plan to unfold and watching how Big Pharma get involved from here.
As described in the original "Why Imu is a multi multi bagger " thread post, re_rating in increments will have to slowly take place as more and more boxes get ticked, the pipeline gets de risked, & the data leads to big ticket deals... across multiple platforms. A dream position to be in now with probably less than 12 months to see some Pd1Vax and Cf33 Ph1 data. Yet some can't even see beyond a day or a week.
All you have to do is sit and watch. Just like the top 20 have done and will continue to do so.
IMU Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
